Command Palette

Search for a command to run...

Clinical Trials · NCT02082496

GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations

CompletedPhase 2Liraglutide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
University of Copenhagen
Enrollment
50
Start date
Jun 2014
Locations
1 site, Denmark
Primary endpoint
Difference in insulin levels in reponse to GLP-1 RA treatment in obese genetic mutation carriers vs obese controls
View Liraglutide compound reference